Download
s00268-020-05444-y.pdf 296,19KB
WeightNameValue
1000 Titel
  • Diltiazem Prophylaxis for the Prevention of Atrial Fibrillation in Patients Undergoing Thoracoabdominal Esophagectomy: A Retrospective Cohort Study
1000 Autor/in
  1. Hochreiter, Marcel |
  2. Schmidt, Thomas |
  3. Siegler, Benedikt H. |
  4. Sisic, Leila |
  5. Schmidt, Karsten |
  6. Bruckner, Thomas |
  7. Müller-Stich, Beat P. |
  8. Diener, Markus K. |
  9. Weigand, Markus A. |
  10. Büchler, Markus W. |
  11. Busch, Cornelius J. |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-03-04
1000 Erschienen in
1000 Quellenangabe
  • 44(7):2295-2304
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00268-020-05444-y |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266852/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Atrial fibrillation (AF) represents the most frequent arrhythmic disorder after thoracoabdominal esophageal resection and is associated with a significant increase in perioperative morbidity and mortality.!##!Methods!#!In this retrospective cohort study, 167 patients who underwent thoracoabdominal esophagectomy at a large university hospital were assessed. We compared patients who received a 14-day postoperative course of diltiazem with a control group of patients who did not undergo diltiazem prophylaxis. Diltiazem therapy started immediately upon admission to the intensive care unit (ICU) with a loading dose of 0.25 mg/kg bodyweight (i.v.) followed by continuous infusion (0.1 mg/kg bodyweight/h) for 40-48 h. Oral administration (Dilzem!##!Results!#!A total of 117 patients were assessed. Twelve (10.3%) of all patients developed postoperative new-onset atrial fibrillation in the first 30 days after surgical intervention. Prevalence of new-onset AF showed no significant differences between the diltiazem group and control group (p = 0.74). The prevalence of bradycardia (14.7% vs. 3.6%; p = 0.03) and dose of norepinephrine required (0.09 vs. 0.04 µg/kg bodyweight/min; p = 0.04) were higher in the diltiazem group. There were no significant differences between the groups for the median postoperative duration of hospital/ICU stay or mortality.!##!Conclusions!#!A prophylactic 14-day postoperative course of diltiazem was not associated with a reduction in new-onset AF or 30-day mortality following thoracoabdominal esophagectomy. Prophylactic diltiazem therapy was associated with drug-related adverse effects such as bradycardia and increased requirement of norepinephrine. German Clinical Trial Registration Number: DKRS00016631.
1000 Sacherschließung
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal Postoperative Care/methods [MeSH]
lokal Postoperative Complications/epidemiology [MeSH]
lokal General Surgery
lokal Cardiac Surgery
lokal Administration, Oral [MeSH]
lokal Atrial Fibrillation/prevention
lokal Male [MeSH]
lokal Postoperative Complications/prevention
lokal Surgery
lokal Cardiovascular Agents/therapeutic use [MeSH]
lokal Adolescent [MeSH]
lokal Female [MeSH]
lokal Follow-Up Studies [MeSH]
lokal Adult [MeSH]
lokal Vascular Surgery
lokal Humans [MeSH]
lokal Treatment Outcome [MeSH]
lokal Thoracic Surgery
lokal Drug Administration Schedule [MeSH]
lokal Retrospective Studies [MeSH]
lokal Infusions, Intravenous [MeSH]
lokal Middle Aged [MeSH]
lokal Original Scientific Report
lokal Atrial Fibrillation/etiology [MeSH]
lokal Esophagectomy/methods [MeSH]
lokal Diltiazem/therapeutic use [MeSH]
lokal Young Adult [MeSH]
lokal Atrial Fibrillation/epidemiology [MeSH]
lokal Abdominal Surgery
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/SG9jaHJlaXRlciwgTWFyY2Vs|https://frl.publisso.de/adhoc/uri/U2NobWlkdCwgVGhvbWFz|https://frl.publisso.de/adhoc/uri/U2llZ2xlciwgQmVuZWRpa3QgSC4=|https://frl.publisso.de/adhoc/uri/U2lzaWMsIExlaWxh|https://frl.publisso.de/adhoc/uri/U2NobWlkdCwgS2Fyc3Rlbg==|https://frl.publisso.de/adhoc/uri/QnJ1Y2tuZXIsIFRob21hcw==|https://frl.publisso.de/adhoc/uri/TcO8bGxlci1TdGljaCwgQmVhdCBQLg==|https://frl.publisso.de/adhoc/uri/RGllbmVyLCBNYXJrdXMgSy4=|https://frl.publisso.de/adhoc/uri/V2VpZ2FuZCwgTWFya3VzIEEu|https://frl.publisso.de/adhoc/uri/QsO8Y2hsZXIsIE1hcmt1cyBXLg==|https://frl.publisso.de/adhoc/uri/QnVzY2gsIENvcm5lbGl1cyBKLg==
1000 Hinweis
  • DeepGreen-ID: 6a9a77d4cb66451494c7a1b351078d3a ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6470096.rdf
1000 Erstellt am 2023-11-18T03:51:56.559+0100
1000 Erstellt von 322
1000 beschreibt frl:6470096
1000 Zuletzt bearbeitet Fri Dec 01 11:09:05 CET 2023
1000 Objekt bearb. Fri Dec 01 11:09:05 CET 2023
1000 Vgl. frl:6470096
1000 Oai Id
  1. oai:frl.publisso.de:frl:6470096 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source